| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |